NovaBridge Biosciences (NBP) EPS (Basic) (2020 - 2025)
NovaBridge Biosciences (NBP) posted quarterly EPS (Basic) of -$0.33 for Q4 2025, down 279.74% year-over-year from $0.18 in Q4 2024, and down 893.56% quarter-over-quarter from -$0.03 in Q3 2025.
Analysis
NovaBridge Biosciences (NBP) EPS (Basic) (2020 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported EPS (Basic) for 5 consecutive years, with -$0.33 the latest figure, recorded in Q4 2025.
- In Q4 2025, EPS (Basic) fell 279.74% year-over-year to -$0.33; the TTM figure through Dec 2025 stood at -$0.4 (down 1173.7% YoY), while the FY2024 annual figure was $0.15, up 113.64% from the prior year.
- EPS (Basic) fell to -$0.33 in Q4 2025 per NBP's latest filing, from -$0.03 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.18 in Q4 2024 and bottomed at -$0.33 in Q4 2025.
- Historically, EPS (Basic) has averaged -$0.05 across 3 years, with a median of -$0.03 in 2025.
- On a YoY basis, EPS (Basic) climbed as much as 69.7% in 2025 and fell as far as 4193524.42% in 2025.
- NovaBridge Biosciences' EPS (Basic) stood at -$0.17 in 2023, then surged by 206.76% to $0.18 in 2024, then plunged by 279.74% to -$0.33 in 2025.
- Business Quant data shows NBP's EPS (Basic) at -$0.33 in Q4 2025, -$0.03 in Q3 2025, and -$0.03 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | NovaBridge Biosciences | 199.33 Mn | 199.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -0.80 |
| Sep 30, 2025 | 0.09 |
| Jun 30, 2025 | -0.06 |
| Mar 31, 2025 | -0.03 |
| Dec 31, 2024 | -0.24 |
| Sep 30, 2024 | -0.21 |
| Jun 30, 2024 | 0.26 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | -0.70 |
| Sep 30, 2023 | -0.35 |
| Jun 30, 2023 | -0.65 |
| Dec 31, 2020 | 2.34 |